Northwell Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).
Northwell Health: 370 sponsored US clinical trials, 81 recruiting.
Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.
Top-decile sponsor footprint
Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
370 total, page 8 of 8
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
NCT00665613
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
NCT00169988
Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research
NCT00926042
Study of Pulmozyme to Treat Severe Asthma Episodes
NCT00169962
Aripiprazole Treatment of the Prodrome
NCT00169949
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
NCT02539433
Pain in Traumatic Brain Injury - Basile, MD
NCT01136486
Genetic Registry for Rheumatoid Arthritis
NCT00069472
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
NCT00298818
Treatment and Outcome of Early Onset Bipolar Disorder
NCT00048802
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
NCT00225498
Pilot Study of Mycophenolate Mofetil in Congenital Uropathies
NCT00193635
Treating Drug-Resistant Childhood Schizophrenia
NCT00048828
Observational Study of Lamotrigine
NCT00299793
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
NCT01110850
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
NCT00042224
Olanzapine in the Treatment of Anorexia Nervosa
NCT00592930
B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression
NCT01030913
Treatment for First-Episode Schizophrenia
NCT00000374
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
NCT01028430
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 30 |
| Phase 3 | 12 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Northwell Health pipeline
81 recruiting of 370 indexed (22% open); 209 completed (56%).
Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwell Health: open-pipeline peers nationwide
Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 370 trials (± recruiting share)
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 22% open enrollment (± trial volume)
- St. Jude Children's Research Hospital · 22% recruiting · 410 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- AtriCure · 22% recruiting · 23 trials
- University of Colorado, Boulder · 22% recruiting · 69 trials
Related
What to do with this Northwell Health page
370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.
- 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.